Published in Mol Inform on June 02, 2014
Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions. Chem Biol (2015) 0.91
Flexibility and small pockets at protein-protein interfaces: New insights into druggability. Prog Biophys Mol Biol (2015) 0.90
MTiOpenScreen: a web server for structure-based virtual screening. Nucleic Acids Res (2015) 0.88
Marine natural products as breast cancer resistance protein inhibitors. Mar Drugs (2015) 0.80
Alternative modulation of protein-protein interactions by small molecules. Curr Opin Biotechnol (2015) 0.79
The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular Diseases. Front Pharmacol (2016) 0.78
DARC 2.0: Improved Docking and Virtual Screening at Protein Interaction Sites. PLoS One (2015) 0.78
How an Inhibitor Bound to Subunit Interface Alters Triosephosphate Isomerase Dynamics. Biophys J (2015) 0.78
Motif mediated protein-protein interactions as drug targets. Cell Commun Signal (2016) 0.76
Molecular docking as a popular tool in drug design, an in silico travel. Adv Appl Bioinform Chem (2016) 0.76
A Tryptoline Ring Distortion Strategy Leads to Complex and Diverse Biologically Active Molecules from the Indole Alkaloid Yohimbine. Chemistry (2016) 0.75
iPPI-DB: an online database of modulators of protein-protein interactions. Nucleic Acids Res (2015) 0.75
Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors. Sci Rep (2017) 0.75
In silico identification of essential proteins in Corynebacterium pseudotuberculosis based on protein-protein interaction networks. BMC Syst Biol (2016) 0.75
The Protein Data Bank. Nucleic Acids Res (2000) 187.10
Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 103.76
A novel genetic system to detect protein-protein interactions. Nature (1989) 43.83
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev (2001) 36.00
The Database of Interacting Proteins: 2004 update. Nucleic Acids Res (2004) 23.67
STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res (2012) 18.26
The HUPO PSI's molecular interaction format--a community standard for the representation of protein interaction data. Nat Biotechnol (2004) 16.08
Principles of protein-protein interactions. Proc Natl Acad Sci U S A (1996) 14.51
How many drug targets are there? Nat Rev Drug Discov (2006) 14.22
The druggable genome. Nat Rev Drug Discov (2002) 13.61
Angiogenesis as a therapeutic target. Nature (2005) 11.89
A hot spot of binding energy in a hormone-receptor interface. Science (1995) 10.41
Anatomy of hot spots in protein interfaces. J Mol Biol (1998) 9.70
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature (2007) 9.12
The BioGRID Interaction Database: 2011 update. Nucleic Acids Res (2010) 8.46
Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov (2004) 7.84
The IntAct molecular interaction database in 2012. Nucleic Acids Res (2011) 7.49
Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res (2004) 7.39
Interactome networks and human disease. Cell (2011) 7.16
iPfam: visualization of protein-protein interactions in PDB at domain and amino acid resolutions. Bioinformatics (2004) 7.02
An empirical framework for binary interactome mapping. Nat Methods (2008) 6.59
New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem (2010) 6.54
The FoldX web server: an online force field. Nucleic Acids Res (2005) 6.30
MINT, the molecular interaction database: 2012 update. Nucleic Acids Res (2011) 5.25
Virtual screening of chemical libraries. Nature (2004) 4.84
The MIPS mammalian protein-protein interaction database. Bioinformatics (2004) 4.66
The structure of protein-protein recognition sites. J Biol Chem (1990) 4.55
Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. J Med Chem (2003) 4.49
Estimating the size of the human interactome. Proc Natl Acad Sci U S A (2008) 3.66
The future of peptide-based drugs. Chem Biol Drug Des (2013) 3.41
Structure-based prediction of protein-protein interactions on a genome-wide scale. Nature (2012) 3.37
Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal (2007) 3.36
Diversity of protein-protein interactions. EMBO J (2003) 3.35
Comparing antibody and small-molecule therapies for cancer. Nat Rev Cancer (2006) 3.19
ProMate: a structure based prediction program to identify the location of protein-protein binding sites. J Mol Biol (2004) 3.18
Protein interaction data curation: the International Molecular Exchange (IMEx) consortium. Nat Methods (2012) 3.17
Principles of protein-protein interactions: what are the preferred ways for proteins to interact? Chem Rev (2008) 2.96
Modeling electrostatic effects in proteins. Biochim Biophys Acta (2006) 2.91
The impact of natural products upon modern drug discovery. Curr Opin Chem Biol (2008) 2.84
Protein-protein interaction and quaternary structure. Q Rev Biophys (2008) 2.64
Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther (2013) 2.64
Flexible ligand docking to multiple receptor conformations: a practical alternative. Curr Opin Struct Biol (2008) 2.38
Anchor residues in protein-protein interactions. Proc Natl Acad Sci U S A (2004) 2.35
Virtual screening: an endless staircase? Nat Rev Drug Discov (2010) 2.26
Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg Med Chem Lett (2008) 2.17
ProtorP: a protein-protein interaction analysis server. Bioinformatics (2008) 2.09
QSAR modeling: where have you been? Where are you going to? J Med Chem (2014) 2.08
Grasping at molecular interactions and genetic networks in Drosophila melanogaster using FlyNets, an Internet database. Nucleic Acids Res (1999) 2.03
Inhibition of α-helix-mediated protein-protein interactions using designed molecules. Nat Chem (2013) 2.02
Generation of a set of simple, interpretable ADMET rules of thumb. J Med Chem (2008) 1.99
Structural conservation of druggable hot spots in protein-protein interfaces. Proc Natl Acad Sci U S A (2011) 1.95
Prediction-based fingerprints of protein-protein interactions. Proteins (2007) 1.92
Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective. Curr Opin Chem Biol (2010) 1.91
Getting pharmaceutical R&D back on target. Nat Chem Biol (2011) 1.90
Protein interface conservation across structure space. Proc Natl Acad Sci U S A (2010) 1.82
In silico pharmacology for drug discovery: applications to targets and beyond. Br J Pharmacol (2007) 1.78
In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br J Pharmacol (2007) 1.77
ISIS: interaction sites identified from sequence. Bioinformatics (2007) 1.71
3did: identification and classification of domain-based interactions of known three-dimensional structure. Nucleic Acids Res (2010) 1.71
Virtual screening strategies in drug discovery. Curr Opin Chem Biol (2007) 1.67
Inhibition of protein-protein association by small molecules: approaches and progress. J Med Chem (2002) 1.66
Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes. ACS Chem Neurosci (2010) 1.66
Atomic interactions and profile of small molecules disrupting protein-protein interfaces: the TIMBAL database. Chem Biol Drug Des (2009) 1.64
DASMI: exchanging, annotating and assessing molecular interaction data. Bioinformatics (2009) 1.64
The anticoagulant protein C pathway. FEBS Lett (2005) 1.56
Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors. J Med Chem (2010) 1.54
Human cancer protein-protein interaction network: a structural perspective. PLoS Comput Biol (2009) 1.54
Small molecular weight protein-protein interaction antagonists: an insurmountable challenge? Curr Opin Chem Biol (2008) 1.53
meta-PPISP: a meta web server for protein-protein interaction site prediction. Bioinformatics (2007) 1.52
Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I). Curr Opin Chem Biol (2011) 1.49
Transient pockets on protein surfaces involved in protein-protein interaction. J Med Chem (2007) 1.49
A survey of available tools and web servers for analysis of protein-protein interactions and interfaces. Brief Bioinform (2009) 1.47
Disrupting protein-protein interactions with non-peptidic, small molecule alpha-helix mimetics. Curr Opin Chem Biol (2010) 1.47
Homology modeling in drug discovery: current trends and applications. Drug Discov Today (2009) 1.47
The road less traveled: modulating signal transduction enzymes by inhibiting their protein-protein interactions. Curr Opin Chem Biol (2009) 1.46
Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition. Arterioscler Thromb Vasc Biol (2005) 1.46
Predicting druggable binding sites at the protein-protein interface. Drug Discov Today (2008) 1.45
Modulation of protein-protein interactions with small organic molecules. Angew Chem Int Ed Engl (2003) 1.44
Finding the sweet spot: the role of nature and nurture in medicinal chemistry. Nat Rev Drug Discov (2012) 1.43
Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery. Trends Pharmacol Sci (2005) 1.43
Polypharmacology - foe or friend? J Med Chem (2013) 1.42
Inhibition of protein-protein interactions using designed molecules. Chem Soc Rev (2009) 1.40
A simple definition of structural regions in proteins and its use in analyzing interface evolution. J Mol Biol (2010) 1.40
Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17. J Chem Inf Model (2012) 1.39
Emerging classes of protein-protein interaction inhibitors and new tools for their development. Curr Opin Chem Biol (2004) 1.38
Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene (2000) 1.38
Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs. AAPS J (2009) 1.37
Molecular docking screens using comparative models of proteins. J Chem Inf Model (2009) 1.36
From in silico target prediction to multi-target drug design: current databases, methods and applications. J Proteomics (2011) 1.35
Structural space of protein-protein interfaces is degenerate, close to complete, and highly connected. Proc Natl Acad Sci U S A (2010) 1.34
Human diseases through the lens of network biology. Trends Genet (2012) 1.34
The Biomolecular Interaction Network Database in PSI-MI 2.5. Database (Oxford) (2011) 1.34
Protein-protein complex structure predictions by multimeric threading and template recombination. Structure (2011) 1.34
Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery. Drug Discov Today (2010) 1.33
The influence of the 'organizational factor' on compound quality in drug discovery. Nat Rev Drug Discov (2011) 1.32
SwarmDock: a server for flexible protein-protein docking. Bioinformatics (2013) 1.32
Discovery of small molecule inhibitors of the interaction of the thyroid hormone receptor with transcriptional coregulators. J Biol Chem (2005) 1.32
HPIDB--a unified resource for host-pathogen interactions. BMC Bioinformatics (2010) 1.31
HotPoint: hot spot prediction server for protein interfaces. Nucleic Acids Res (2010) 1.30